Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS??? EQUITY

v3.22.2.2
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Dec. 31, 2020 [1]   37,200,000      
Beginning balance at Dec. 31, 2020 [1] $ 39,195 $ 4 $ 53,059 $ (14,374) $ 506
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
GPAC shares net of redemptions, including PIPE, warrant liability, and Merger costs (in shares)   22,461,273      
GPAC shares net of redemptions, including PIPE, warrant liability, and Merger costs 52,921 $ 2 52,919    
Parent’s contributions 2,110   2,110    
Earnout settlement in holding's and parent's equity 9,288   9,288    
Equity-based compensation expense 22,919   22,919    
Foreign currency translation, net of tax (298)       (298)
Net income (loss) (47,827)     (47,827)  
Ending balance (in shares) at Sep. 30, 2021   59,661,273      
Ending balance at Sep. 30, 2021 78,308 $ 6 140,295 (62,201) 208
Beginning balance (in shares) at Jun. 30, 2021 [1]   37,200,000      
Beginning balance at Jun. 30, 2021 [1] 17,551 $ 4 55,169 (37,949) 327
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
GPAC shares net of redemptions, including PIPE, warrant liability, and Merger costs (in shares)   22,461,273      
GPAC shares net of redemptions, including PIPE, warrant liability, and Merger costs 52,921 $ 2 52,919    
Earnout settlement in holding's and parent's equity 9,288   9,288    
Equity-based compensation expense 22,919   22,919    
Foreign currency translation, net of tax (119)       (119)
Net income (loss) (24,252)     (24,252)  
Ending balance (in shares) at Sep. 30, 2021   59,661,273      
Ending balance at Sep. 30, 2021 78,308 $ 6 140,295 (62,201) 208
Beginning balance (in shares) at Dec. 31, 2021   62,690,869      
Beginning balance at Dec. 31, 2021 107,222 $ 6 183,024 (75,911) 103
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Equity-based compensation expense 8,672   8,672    
Common stock issued under the committed equity facility (in shares)   909,669      
Common stock issued under the committed equity facility 3,047   3,047    
Committed equity facility fee settled in common stock (in shares)   127,751      
Committed equity facility fee settled in common stock 756   756    
Foreign currency translation, net of tax (663)       (663)
Net income (loss) (104,744)     (104,744)  
Other (in shares)   124,401      
Other 513   513    
Ending balance (in shares) at Sep. 30, 2022   63,852,690      
Ending balance at Sep. 30, 2022 14,803 $ 6 196,012 (180,655) (560)
Beginning balance (in shares) at Jun. 30, 2022   63,253,836      
Beginning balance at Jun. 30, 2022 21,098 $ 6 191,707 (170,232) (383)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Equity-based compensation expense 2,518   2,518    
Common stock issued under the committed equity facility (in shares)   598,854      
Common stock issued under the committed equity facility 1,787   1,787    
Foreign currency translation, net of tax (177)       (177)
Net income (loss) (10,423)     (10,423)  
Ending balance (in shares) at Sep. 30, 2022   63,852,690      
Ending balance at Sep. 30, 2022 $ 14,803 $ 6 $ 196,012 $ (180,655) $ (560)
[1] The units of the Company prior to the Merger (as defined in Note A) have been retroactively restated to reflect the exchange ratio established in the Merger (computed as 37,200,000 shares of common stock to 100 Company units).